Stocks for the health care company soared Thursday after beating on the top and bottom line and raising guidance for the rest of the year. Diane King Hall joins Alex Coffey and Jenny Horne to talk about the popularity of GLP-1 drugs, and what the success of Mounjaro means for Eli Lilly's (LLY) outlook.